Sales rise 12.06% to Rs 58.34 crore
Net profit of Balaxi Pharmaceuticals rose 23.10% to Rs 10.71 crore in the quarter ended June 2021 as against Rs 8.70 crore during the previous quarter ended June 2020. Sales rose 12.06% to Rs 58.34 crore in the quarter ended June 2021 as against Rs 52.06 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales58.3452.06 12 OPM %19.5217.33 -PBDT12.5610.53 19 PBT12.4910.46 19 NP10.718.70 23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
